Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | DPYSL2 |
| Upstream (Parents) |
|---|
| (<<) HMGCS2 → DPYSL2 |
| (<<) CHN1 → DPYSL2 |
| (<<) DACT1 → DPYSL2 |
| (<<) GAS6 → DPYSL2 |
| (<<) TUBA1A → DPYSL2 |
| (<<) ETV5 → DPYSL2 |
| Downstream (Children) |
|---|
| DPYSL2 → RIMBP2 (>>) |
| DPYSL2 → ADAM7 (>>) |
| DPYSL2 → C17orf53 (>>) |
| DPYSL2 → SULT1B1 (>>) |
| DPYSL2 → ADAM23 (>>) |
| DPYSL2 → SGSH (>>) |
| DPYSL2 → ETV5 (>>) |
| DPYSL2 → WSB1 (>>) |
| DPYSL2 → WASF1 (>>) |
| DPYSL2 → CLN8 (>>) |
| DPYSL2 → MECP2 (>>) |
| DPYSL2 → TXNIP (>>) |
| DPYSL2 → ST3GAL2 (>>) |
